Search Results - "Silva, Sinara Figueiredo"

HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer by de Moura Leite, Luciana, Cesca, Marcelle Goldner, Tavares, Monique Celeste, Santana, Debora Maciel, Saldanha, Erick Figueiredo, Guimarães, Paula Tavares, Sá, Daniella Dias Silva, Simões, Maria Fernanda Evangelista, Viana, Rafael Lima, Rocha, Francisca Giselle, Loose, Simone Klog, Silva, Sinara Figueiredo, Pirolli, Rafaela, Fogassa, Camilla Albina Zanco, Mattos, Bruna Raphaeli Silva, Campos, Fernando Augusto Batista, Sanches, Solange Moraes, de Lima, Vladmir Cláudio Cordeiro, Pondé, Noam Falbel

“…Purpose Knowledge on whether low expressions of HER2 have prognostic impact in early-stage breast cancer (BC) and on its response to current chemotherapy…”
Get full text

Adjuvant therapy in non-metastatic melanoma result from a Brazilian cohort by Silva, Sinara Figueiredo, Tavares, Monique Celeste, De Barros E Silva, Milton Jos, Rinck, José Augusto, Lima, Joao Paulo SN, Garcia, Daniel, Calsavara, Vinicius Fernando

“…Abstract only e22095 Background: The PD-1–blocking antibodies, combination of target therapy and anti-CTLA4 have shown a favorable safety profile with better…”
Get full text

Abstract PS4-40: Her2 low status and response to neoadjuvant chemotherapy in Her2 negative early breast cancer by Mattos, Bruna RaphaeliSilva, Cesca, Marcelle Goldner, de Moura Leite, Luciana, Tavares, Monique Celeste, Silva, Sinara Figueiredo, Pirolli, Rafaela, Fogassa, Camilla AlbinaZanco, Silva, Erick Figueiredo, Rocha, Francisca Giselle, Loose, Simone Klug, Campos, Fernando AugustoBatista, Sanches, Solange Moraes, de Lima, Vladmir ClaudioCordeiro, Pondé, Noam Falbel

“…Background: HER2-positive status has for 20 years defined a subgroup of breast cancer (BC) patients who benefit from anti-HER2 therapies. Studies testing…”
Get full text

Discordance between molecular subtyping from pre- and post-neoadjuvant chemotherapy (NACT) biopsy specimens in a Brazilian breast cancer cohort by Tavares, Monique Celeste, Leite, Luciana de Moura, Cesca, Marcelle Goldner, de Andrade, Poliana, Pirolli, Rafaela, Xerfan, Mariana Pinheiro, Oliveira, Fernanda A., Silva, Sinara Figueiredo, Zanco Fogassa, Camilla Albina, Mattos, Bruna Raphaeli Silva, Campos, Fernando Augusto Batista, Sanches, Solange Moraes, Cordeiro De Lima, Vladmir Claudio

“…Abstract only e12649 Background: Discordance between immunohistochemistry (IHC) and molecular subtyping from pre and post neoadjuvant chemotherapy (NACT)…”
Get full text